New PowerTOST function(s) [Regulatives / Guidelines]

posted by d_labes  – Berlin, Germany, 2015-09-22 16:59 (3433 d 19:58 ago) – Posting: # 15449
Views: 17,204

Dear Helmut,

❝ welcome back! How was vacation on the lonesome isle far out on the high seas?


Thanks! It was very recreative. And I could practise what I have to do if I will be a rendeer (German Rentier) next time.
Doing nothing the whole blessed day but "Maulaffen feil halten" (to gawk, to sit on one's hands) :cool:.

❝ I would not add other argument(s) to power.NTIDFDA(). AFAIK dabigatran is not a NTID.


That astonishes me. I had interpreted the sentence "Dabigatran demonstrated a steep exposure response relationship for both efficacy and safety." as some sort of NTID.

❝ Let’s ask Ben as well.


Good idea. I will wait for his reaction.

BTW: Do you think this sort of BE evaluation is not an "Eintagsfliege" (nine day wonder, ephemera), specific for dabigatran?

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
93 visitors (0 registered, 93 guests [including 8 identified bots]).
Forum time: 11:57 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5